Please Wait

Applying Filters...

Looking for Aflibercept? Find Controlled & Modified Release used in Aflibercept to address drug delivery challenges on PharmaCompass.

Aflibercept

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

2 API Suppliers, 2 Listed Suppliers

DEVELOPMENTS

60 Drugs in Development

60 Drugs in Development

FINISHED DOSAGE FORMULATIONS

34 FDF Dossiers, 3 FDA Orange Book, 12 Europe, 2 Canada, 16 Australia, 1 South Africa

RELATED EXCIPIENT COMPANIES

1 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 6 Actylis, 1 BASF, 1 Gangwal Chemicals, 2 Seppic

EXCIPIENTS BY APPLICATIONS

6 Parenteral, 4 Solubilizers, 3 Thickeners and Stabilizers, 2 Coating Systems & Additives, 2 Topical, 2 Surfactant & Foaming Agents, 2 Controlled & Modified Release, 2 Taste Masking, 1 Emulsifying Agents

DIGITAL CONTENT

4 DATA COMPILATION #PharmaFlow, 1 STOCK RECAP #PipelineProspector, 195 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

9 Finished Drug Prices, 29 Annual Reports

MARKET PLACE

6 APIs, 9 FDF Dossiers

Xls

Filters

Aflibercept

Filters

FILTER :

filter Company Reset all filters

4 All

01 4Actylis

filter Capability Reset all filters

filter Country Reset all filters

01

Actylis

SODIUM CITRATE DIHYDRATE MULTI-COMPENDIAL

Antibody Engineering

Not Confirmed

02

Actylis

SODIUM CITRATE DIHYDRATE USP-NF

Antibody Engineering

Not Confirmed